findmyKOL
Clinical trialNCT02427464CompletedPhase 3Interventional

Phase 3 Gene Therapy for Painful Diabetic Neuropathy

SponsorHelixmith Co., Ltd.Enrollment507Diabetic Neuropathy, PainfulPainful Diabetic Neuropathy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Research Center

    Phoenix, Arizona, United States

  • Clinical Trials, Inc.

    Little Rock, Arkansas, United States

  • Richard S. Cherlin, Md

    Los Gatos, California, United States

  • Northern California Research

    Sacramento, California, United States

  • Center for Clinical Research

    San Francisco, California, United States

  • Neurological Research Institute

    Santa Monica, California, United States

  • Diablo Clinical Research, Inc.

    Walnut Creek, California, United States

  • Associated Neurologists of Southern Connecticut, Pc

    Fairfield, Connecticut, United States

  • Innovative Research of West Florida

    Clearwater, Florida, United States

  • University of Florida Mcknight Brain Institute

    Gainesville, Florida, United States

  • Uf Health College of Med, Jacksonville

    Jacksonville, Florida, United States

  • Compass Research, Llc

    Orlando, Florida, United States

  • Clinical Research of West Florida

    Tampa, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • University of Kansas Medical Center Research Institute

    Kansas City, Kansas, United States

  • the Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Columbia University Medical Center Department of Neurology

    New York, New York, United States

  • Raleigh Neurology Associates, P.A.

    Raleigh, North Carolina, United States

  • Martin Foot and Ankle

    York, Pennsylvania, United States

  • Nerve and Muscle Center of Texas

    Houston, Texas, United States

  • University of Utah -Neurology

    Salt Lake City, Utah, United States

  • Evms (eastern Virginia Medical School)

    Norfolk, Virginia, United States

  • Western Washington Medical Group

    Everett, Washington, United States

  • Rainier Clinical Research Center, Inc.

    Renton, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2016
Primary completion
30 Apr 2019
Completion
30 Apr 2019
Last update posted
9 Oct 2025
Registered enrollment
507
Registry id
NCT02427464

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.